HALO
Price
$107.20
Change
+$0.20 (+0.19%)
Updated
Sep 11 closing price
Capitalization
12.16B
58 days until earnings call
Intraday BUY SELL Signals
MNKD
Price
$3.75
Change
-$0.04 (-1.06%)
Updated
Sep 11 closing price
Capitalization
1.21B
59 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HALO vs MNKD

HALO vs MNKD Comparison Chart in %
View a ticker or compare two or three
VS
HALO vs. MNKD commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Hold and MNKD is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HALO($12.2B) has a higher market cap than MNKD($1.21B). MNKD has higher P/E ratio than HALO: MNKD (143.00) vs HALO (31.43). HALO YTD gains are higher at: 59.287 vs. MNKD (-33.862). HALO has higher annual earnings (EBITDA): 718M vs. MNKD (20.4M). HALO has more cash in the bank: 231M vs. MNKD (111M). MNKD has less debt than HALO: MNKD (331M) vs HALO (2.15B). HALO has higher revenues than MNKD: HALO (1.66B) vs MNKD (394M).
HALOMNKDHALO / MNKD
Capitalization12.2B1.21B1,009%
EBITDA718M20.4M3,520%
Gain YTD59.287-33.862-175%
P/E Ratio31.43143.0022%
Revenue1.66B394M422%
Total Cash231M111M208%
Total Debt2.15B331M649%
FUNDAMENTALS RATINGS
HALO vs MNKD: Fundamental Ratings
HALO
MNKD
OUTLOOK RATING
1..100
7975
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
94
Overvalued
PROFIT vs RISK RATING
1..100
18100
SMR RATING
1..100
11100
PRICE GROWTH RATING
1..100
3649
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a29

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HALO's Valuation (89) in the Biotechnology industry is in the same range as MNKD (94). This means that HALO’s stock grew similarly to MNKD’s over the last 12 months.

HALO's Profit vs Risk Rating (18) in the Biotechnology industry is significantly better than the same rating for MNKD (100). This means that HALO’s stock grew significantly faster than MNKD’s over the last 12 months.

HALO's SMR Rating (11) in the Biotechnology industry is significantly better than the same rating for MNKD (100). This means that HALO’s stock grew significantly faster than MNKD’s over the last 12 months.

HALO's Price Growth Rating (36) in the Biotechnology industry is in the same range as MNKD (49). This means that HALO’s stock grew similarly to MNKD’s over the last 12 months.

MNKD's P/E Growth Rating (5) in the Biotechnology industry is in the same range as HALO (9). This means that MNKD’s stock grew similarly to HALO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HALOMNKD
RSI
ODDS (%)
Bearish Trend 2 days ago
59%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
63%
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 5 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
62%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
61%
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
73%
COMPARISON
Comparison
Sep 12, 2026
Stock price -- (HALO: $107.20 vs. MNKD: $3.75)
Brand notoriety: HALO and MNKD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 51% vs. MNKD: 59%
Market capitalization -- HALO: $12.16B vs. MNKD: $1.21B
HALO [@Biotechnology] is valued at $12.16B. MNKD’s [@Biotechnology] market capitalization is $1.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 3 FA rating(s) are green while MNKD’s FA Score has 1 green FA rating(s).

  • HALO’s FA Score: 3 green, 2 red.
  • MNKD’s FA Score: 1 green, 4 red.
According to our system of comparison, HALO is a better buy in the long-term than MNKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 3 TA indicator(s) are bullish while MNKD’s TA Score has 3 bullish TA indicator(s).

  • HALO’s TA Score: 3 bullish, 5 bearish.
  • MNKD’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, HALO is a better buy in the short-term than MNKD.

Price Growth

HALO (@Biotechnology) experienced а -2.71% price change this week, while MNKD (@Biotechnology) price change was -7.64% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

HALO is expected to report earnings on Nov 09, 2026.

MNKD is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
MNKD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWMMX67.620.28
+0.42%
American Funds Washington Mutual 529-F-2
JCNRX28.80N/A
N/A
Janus Henderson Contrarian R
LOMAX18.81N/A
N/A
Edgar Lomax Value
ASLAX14.58N/A
N/A
AB Select US Long/Short A
VTAIX9.54N/A
N/A
Virtus Tactical Allocation I

MNKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNKD has been loosely correlated with VCYT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if MNKD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNKD
1D Price
Change %
MNKD100%
-1.06%
VCYT - MNKD
44%
Loosely correlated
-2.76%
UTHR - MNKD
37%
Loosely correlated
-1.34%
AMRN - MNKD
36%
Loosely correlated
-1.71%
AXON - MNKD
35%
Loosely correlated
+0.10%
VIR - MNKD
32%
Poorly correlated
+0.38%
More